STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE III PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Short radiation blitz tested to stop prostate Cancer's return
Disease control OngoingThis study is testing a short, high-precision form of radiation therapy for men whose prostate cancer shows signs it might come back after surgery. The goal is to see if this 5-treatment approach is as effective as traditional, longer radiation courses at keeping the cancer away,…
Matched conditions: STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for men with recurrent prostate cancer: can a drug boost Radiation's punch?
Disease control OngoingThis study is for men whose prostate cancer has returned after surgery. It tests if adding a drug called apalutamide to standard radiation therapy works better than radiation alone to keep the cancer from progressing. Apalutamide works by blocking hormones that can fuel prostate …
Matched conditions: STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC